{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:53:48Z","timestamp":1772430828661,"version":"3.50.1"},"reference-count":17,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["823666"],"award-info":[{"award-number":["823666"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010666","name":"H2020 Research Infrastructures","doi-asserted-by":"publisher","award":["653316"],"award-info":[{"award-number":["653316"]}],"id":[{"id":"10.13039\/100010666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Real-time molecular techniques have become the reference methods for direct diagnosis of pathogens. The reduction of steps is a key factor in order to decrease the risk of human errors resulting in invalid series and delayed results. We describe here a process of preparation of oligonucleotide primers and hydrolysis probe in a single tube at predefined optimized concentrations that are stabilized via lyophilization (Lyoph-P&amp;P). Lyoph-P&amp;P was compared versus the classic protocol using extemporaneously prepared liquid reagents using (i) sensitivity study, (ii) long-term stability at 4 \u00b0C, and (iii) long-term stability at 37 \u00b0C mimicking transportation without cold chain. Two previously published molecular assays were selected for this study. They target two emerging viruses that are listed on the blueprint of the WHO as to be considered for preparedness and response actions: chikungunya virus (CHIKV) and Rift Valley fever phlebovirus (RVFV). Results of our study demonstrate that (i) Lyoph-P&amp;P is stable for at least 4 days at 37 \u00b0C supporting shipping without the need of cold chain, (ii) Lyoph-P&amp;P rehydrated solution is stable at +4 \u00b0C for at least two weeks, (iii) sensitivity observed with Lyoph-P&amp;P is at least equal to, often better than, that observed with liquid formulation, (iv) validation of results observed with low-copy specimens is rendered easier by higher fluorescence level. In conclusion, Lyoph-P&amp;P holds several advantages over extemporaneously preparer liquid formulation that merit to be considered when a novel real-time molecular assay is implemented in a laboratory in charge of routine diagnostic activity.<\/jats:p>","DOI":"10.3390\/v12020159","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T01:25:51Z","timestamp":1580693151000},"page":"159","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Lyophilized Matrix Containing Ready-to-Use Primers and Probe Solution for Standardization of Real-Time PCR and RT-qPCR Diagnostics in Virology"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4301-2944","authenticated-orcid":false,"given":"Laurence","family":"Thirion","sequence":"first","affiliation":[{"name":"Unit\u00e9 des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU M\u00e9diterran\u00e9e Infection), 13005 Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Dubot-Peres","sequence":"additional","affiliation":[{"name":"Unit\u00e9 des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU M\u00e9diterran\u00e9e Infection), 13005 Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7921-9221","authenticated-orcid":false,"given":"Laura","family":"Pezzi","sequence":"additional","affiliation":[{"name":"Unit\u00e9 des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU M\u00e9diterran\u00e9e Infection), 13005 Marseille, France"},{"name":"EA7310, Laboratoire de Virologie, Universit\u00e9 de Corse-Inserm, 20250 Corte, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iban","family":"Corcostegui","sequence":"additional","affiliation":[{"name":"Unit\u00e9 des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU M\u00e9diterran\u00e9e Infection), 13005 Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mhammed","family":"Touinssi","sequence":"additional","affiliation":[{"name":"Unit\u00e9 des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU M\u00e9diterran\u00e9e Infection), 13005 Marseille, France"},{"name":"Etablissement Fran\u00e7ais du Sang Alpes M\u00e9diterran\u00e9e, 13005 Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"de Lamballerie","sequence":"additional","affiliation":[{"name":"Unit\u00e9 des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU M\u00e9diterran\u00e9e Infection), 13005 Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7675-8251","authenticated-orcid":false,"given":"Remi","family":"Charrel","sequence":"additional","affiliation":[{"name":"Unit\u00e9 des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU M\u00e9diterran\u00e9e Infection), 13005 Marseille, France"},{"name":"Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/14737159.9.2.187","article-title":"Reliability of Real-Time Reverse-Transcription PCR in Clinical Diagnostics: Gold Standard or Substandard?","volume":"9","author":"Murphy","year":"2009","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/CMR.00003-14","article-title":"Emerging Technologies for the Clinical Microbiology Laboratory","volume":"27","author":"Buchan","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ramanan, P., Bryson, A.L., Binnicker, M.J., Pritt, B.S., and Patel, R. (2017). Syndromic Panel-Based Testing in Clinical Microbiology. Clin. Microbiol. Rev.","DOI":"10.1128\/CMR.00024-17"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bdq.2015.11.001","article-title":"Pitfalls in PCR Troubleshooting: Expect the Unexpected?","volume":"6","author":"Schrick","year":"2015","journal-title":"Biomol. Detect. Quantif."},{"key":"ref_5","unstructured":"WHO (2019, September 23). List of Blueprint priority diseases. Available online: http:\/\/www.who.int\/blueprint\/priority-diseases\/en\/."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jviromet.2004.11.002","article-title":"Development of a TaqMan RT-PCR Assay without RNA Extraction Step for the Detection and Quantification of African Chikungunya Viruses","volume":"124","author":"Pastorino","year":"2005","journal-title":"J. Virol. Methods"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.tibtech.2018.12.002","article-title":"The Ultimate QPCR Experiment: Producing Publication Quality, Reproducible Data the First Time","volume":"37","author":"Taylor","year":"2019","journal-title":"Trends Biotechnol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.sste.2016.04.005","article-title":"Geographically Weighted Discriminant Analysis of Environmental Conditions Associated with Rift Valley Fever Outbreaks in South Africa","volume":"17","author":"Nicholas","year":"2016","journal-title":"Spat. Spatio-Temporal Epidemiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1128\/JCM.40.7.2323-2330.2002","article-title":"Rapid Detection and Quantification of RNA of Ebola and Marburg Viruses, Lassa Virus, Crimean-Congo Hemorrhagic Fever Virus, Rift Valley Fever Virus, Dengue Virus, and Yellow Fever Virus by Real-Time Reverse Transcription-PCR","volume":"40","author":"Drosten","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Monaco, F., Cosseddu, G.M., Doumbia, B., Madani, H., El Mellouli, F., Jim\u00e9nez-Clavero, M.A., Sghaier, S., Marianneau, P., Cetre-Sossah, C., and Polci, A. (2015). First External Quality Assessment of Molecular and Serological Detection of Rift Valley Fever in the Western Mediterranean Region. PLoS ONE.","DOI":"10.1371\/journal.pone.0142129"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Escadafal, C., Paweska, J.T., Grobbelaar, A., le Roux, C., Bouloy, M., Patel, P., Teichmann, A., Donoso-Mantke, O., and Niedrig, M. (2013). International External Quality Assessment of Molecular Detection of Rift Valley Fever Virus. PLoS Negl. Trop. Dis.","DOI":"10.1371\/journal.pntd.0002244"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"880","DOI":"10.2471\/BLT.16.175950","article-title":"Assay Optimization for Molecular Detection of Zika Virus","volume":"94","author":"Corman","year":"2016","journal-title":"Bull. World Health Organ."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jcv.2009.02.010","article-title":"Development and Validation of Real-Time One-Step Reverse Transcription-PCR for the Detection and Typing of Dengue Viruses","volume":"45","author":"Baragatti","year":"2009","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Thirion, L., Pezzi, L., Corcostegui, I., Dubot-P\u00e9r\u00e8s, A., Falchi, A., de Lamballerie, X., and Charrel, R.N. (2019). Development and Evaluation of a Duo Chikungunya Virus Real-Time RT-PCR Assay Targeting Two Regions within the Genome. Viruses, 11.","DOI":"10.3390\/v11080755"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1128\/JCM.00128-16","article-title":"Improved Sensitivity of a Dual-Target HIV-1 Qualitative Test for Plasma and Dried Blood Spots","volume":"54","author":"Templer","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jcv.2010.06.004","article-title":"Improved HIV-1 RNA Quantitation by COBAS AmpliPrep\/COBAS TaqMan HIV-1 Test, v2.0 Using a Novel Dual-Target Approach","volume":"49","author":"Sizmann","year":"2010","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1537-2995.2011.03281.x","article-title":"Blood Screening Nucleic Acid Amplification Tests for Human Immunodeficiency Virus Type 1 May Require Two Different Amplification Targets","volume":"52","author":"Chudy","year":"2012","journal-title":"Transfusion"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/2\/159\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:53:07Z","timestamp":1760172787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/2\/159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["v12020159"],"URL":"https:\/\/doi.org\/10.3390\/v12020159","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]}}}